Home
/ Dizlin
/ Competitors

Dizlin Competitors and Similar CompaniesClear all

Dizlin's competitors and similar companies include AFFiRiS, Addex Therapeutics and IRLAB Therapeutics.

	Dizlin Dizlin Pharmaceuticals is a pharmaceutical research company developing treatments for Parkinson's disease.	AFFiRiS AFFiRiS is a company that delivers therapies to patients with neurodegenerative diseases.	Addex Therapeutics Addex Therapeutics, a development-stage biopharmaceutical company, discovers small-molecule pharmaceutical products.	IRLAB Therapeutics IRLAB Therapeutics is a biotechnology company focused on Parkinson's disease (PD).
Founding Date	Founding Date 2003	Founding Date 2003	Founding Date 2002	Founding Date 2013
Type	Type Private	Type Private	Type Public	Type Public
Tags	Tags Healthcare clinical research drug development pharma	Tags Healthcare biotech pharma therapy	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma
Locations	Locations Göteborg, SE HQ	Locations Wien, AT HQ	Locations Plan-les-Ouates, CH HQ San Francisco, US	Locations Göteborg, SE HQ
Employees	Employees 6	Employees 3	Employees 23	Employees 30
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) CHF30k (FY, 2025)	Revenue (est.) kr57.5m (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit CHF173k (FY, 2025)	Gross profit kr62.8m (FY, 2025)
Net income	Net income N/A	Net income N/A	Net income (CHF6.8m) (FY, 2025)	Net income (kr110m) (FY, 2025)
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 34.1m	Total funding raised $ 94.7m	Total funding raised N/A